% | $
Quotes you view appear here for quick access.

công ty Lpath Message Board

  • fezziwig2008 fezziwig2008 Feb 28, 2013 9:17 AM Flag

    Wait- Is This the Same Lpath That Summer Street Rated a Buy -Price Target $18- 2 Mos Ago?

    : Summer Street Initiates Lpath Incorporated at Buy on Valuation

    David Johnson, Benzinga Staff Writer
    December 27, 2012 11:11 AM


    Summer Street initiated coverage on Lpath Incorporated (NASDAQ: LPTN[FREE Stock Trend Analysis]) with a Buy rating and an $18 price target.

    Summer Street noted, "Lpath's valuation is compelling when compared to other platform companies in similar positions. Our iSONEP royalty projections begin in 2017 at $28MM and grow to $692MM in 2021, despite sharing the frontline market opportunity with a potential anti-PDGF inhibitor. By only including a portion of the frontline AMD market with VEGF inhibitors and the initial market refractory anti-VEGF agent failures, our model may be overly conservative." Lpath Incorporated closed at $4.90 on Wednesday.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.2608+0.0049(+1.91%)Jul 7 4:00 PMEDT